Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis
Autor: | Sandra Casimiro, Ana C Martins Cavaco, Sara Dâmaso, Luis Costa |
---|---|
Přispěvatelé: | Repositório da Universidade de Lisboa |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Cancer Research Collagen fragments Disease Biology Metastasis Extracellular matrix 03 medical and health sciences 0302 clinical medicine Neoplasms medicine Animals Humans Neoplasm Metastasis Cancer Tumor microenvironment Biologic functions medicine.disease Prognostic tools Desmoplasia Pathophysiology 030104 developmental biology Oncology 030220 oncology & carcinogenesis Cancer cell Disease Progression Cancer research Collagen medicine.symptom |
Zdroj: | Cancer and Metastasis Reviews. 39:603-623 |
ISSN: | 1573-7233 0167-7659 |
DOI: | 10.1007/s10555-020-09888-5 |
Popis: | © Springer Science+Business Media, LLC, part of Springer Nature 2020 Progression through dissemination to tumor-surrounding tissues and metastasis development is a hallmark of cancer that requires continuous cell-to-cell interactions and tissue remodeling. In fact, metastization can be regarded as a tissue disease orchestrated by cancer cells, leading to neoplastic colonization of new organs. Collagen is a major component of the extracellular matrix (ECM), and increasing evidence suggests that it has an important role in cancer progression and metastasis. Desmoplasia and collagen biomarkers have been associated with relapse and death in cancer patients. Despite the increasing interest in ECM and in the desmoplastic process in tumor microenvironment as prognostic factors and therapeutic targets in cancer, further research is required for a better understanding of these aspects of cancer biology. In this review, published evidence correlating collagen with cancer prognosis is retrieved and analyzed, and the role of collagen and its fragments in cancer pathophysiology is discussed. |
Databáze: | OpenAIRE |
Externí odkaz: |